Keynote Financial Services’s Biogen BIIB Stock Holding History

Keynote Financial Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$211K	Buy	+977	New	+$187K	0.1%	172

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Keynote Financial Services's BIIB Position: Q2 2026 in Review

Keynote Financial Services opened a new position in Biogen (BIIB) in Q2 2026: 977 shares worth $211K. The stake represents 0.1% of the portfolio and ranks #172 among its holdings.

1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Keynote Financial Services held 977 shares of Biogen worth $211K as of Q2 2026.
Biogen was a new Keynote Financial Services position in Q2 2026.
Biogen made up 0.1% of Keynote Financial Services's portfolio in Q2 2026, its #172 holding.
1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Keynote Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.